Blue Horseshoe Stocks: LXRX Recap & Much More

Lexicon Pharmaceuticals, Inc. LXRX

Our first order of business today is to congratulate any of our readers who were able to turn our premarket alert of LXRX into hefty intraday gains.

We were given ample opportunity to do so, as a hugely significant PR left the stock positively charged for most of the session. A momentous intraday run began from an early low of 10.83 and topped out at an HOD of 13.80. That translates to a 27% jump, which is a very impressive single-session performance for a $10 stock.

If you recall, we hit this one from multiple angles; our options trading idea of tracking Weekly $10 Calls was also good for potential profits. Those contracts traded up from a low of 1.50 all the way to 3.90, which was good for gains of up to 160%

LXRX held the majority of its daily advance, which occurred on well over 30-times the 3-month average volume. That sets the stock up with plenty of momentum, and signals us to keep an eye out in coming sessions for a continuation of such. In the event that occurs, as far as options are concerned, we’d roll our strike price up to the Weekly $12.50 Calls, which already made a heck of a move yesterday from .45-2.00.

___

Hutchinson Technology, Inc. HTCH

We also want to give a quick update on HTCH, which we entered into the conversation via Friday’s premarket report. We witnessed the beginning of its run that day with a low of 1.60, and subsequent 22% pop to 1.95.

Yesterday, the stock set a new high of 2.25, which marked a two-day increase of 41% In order for us to remain interested in this play. we’ll need to see it continue to record higher lows.


Super-Subpenny Bottom-Watchlist

Here are a couple of stocks trading in the triple-zero range that we thought were worthy of compiling into a potential bottom-play watchlist as we head into midweek. We’ll include charts for the pair illustrating the reasoning behind that:

  Pervasip Corp. PVSP

B2Digital, Inc. BTDG



Extended Watchlist:

S, FIT($50-51 Weekly Calls), DAL, AAPL(Radar for Eventual Bounce)

Blue Horseshoe Stocks: PVSP Update, PLUG News & More

Pervasip Corp. PVSP

For the second consecutive session, PVSP made higher highs and higher lows yesterday. We re-focused on this old favorite at the end of last week, and caught it trading at a low of .0014. After a solid session to close out the holiday-shortened week, we once again included it in our premarket report yesterday, and the stock kicked this week off on a strong note as well.

We observed a trading range from .0015 to .0021, a 40% intraday push, and an overall range of 50% over our observed low from Thursday.

The heathly activity on the chart can be attributed in part to last week’s acquisition news; PVSP now holds, through its newly-acquired subsidiary, a 60% stake in Denver-based distribution company servicing the hydroponic and indoor cannabis grow market>> Read PR


Plug Power, Inc. PLUG

Speaking of old favorites, PLUG has published a PR today which is standing out among this morning’s top news items, with a very promising announcement of their Q2 figures. Perhaps one of the most notable aspects; the company shipped more than twice as many of its GenDrive fuel cell units as it did in the previous quarter.

This news comes at an opportune time, with the stock having been undergoing a recent downtrend which culminated in the logging of a new 52-week low yesterday. We’re anxious to follow the activity after what is looking like a significant gap-up this morning, in what could turn into a noteworthy rebound-play.

LATHAM, N.Y., July 7, 2015 (GLOBE NEWSWIRE) — Plug Power Inc. (PLUG), a leader in providing clean, reliable energy solutions, today highlighted strong fuel cell and hydrogen infrastructure shipments and installations in the second quarter of 2015 allowing for a record revenue quarter. The company is on track to achieve its previously announced 2015 financial targets. >> FULL PR


Prima BioMed, Ltd. PBMD

Also cropping up on our news scanner this morning is PBMD. It’s no secret that we’ve had an exceptional amount of success with various pharma plays this year, and this could be the next entry into that group.

This morning’s news suggests that the company’s flagship product, a metastatic breast cancer treatment, could be on the path to approval for European markets. The stock is trading at its lowest price since May.

SYDNEY, AUSTRALIA–(Marketwired – Jul 7, 2015) – Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (“Prima” or the “Company”), a leading immuno-oncology company, is pleased to announce that it has received positive Scientific Advice from the European Medicines Agency (“EMA” or the “Agency”) on the development path for its lead product, IMP321 in metastatic breast cancer. >> FULL PR


Extended Watchlist:
ORMP, JDST, MDBX, KALO(Bottom-Watch), OCFN (Possible Momentum-Play)

Blue Horseshoe Stocks: TSLA Options Recap & More

Tesla Motors, Inc. TSLA – Options

Despite another choppy day for the markets as a whole, we were able to find a diamond in the rough with our TSLA Options Idea in Thursday’s premarket report.

As the stock was gapping up, we identified the possibility of some dip-and-rip scenarios occurring in weekly TSLA $275-280 Calls and that’s precisely what we got. There was some extremely impressive action with the $275’s and $277.50’s in particular, that could’ve provided traders with exponential gains.

The $275 Calls jumped out of the starting gate and went on an initial run from 5.00 to 7.60 (+52%) in the first couple minutes of the session. The dip-and-rip we were after provided an even bigger opportunity as the contracts reached a midday low of .78 before rebounding, and absolutely exploded back to a 5.10 close. That marked a second intraday rip of 554%

The $277.50’s traded in a similar pattern; the initial move was from 3.20 to 5.40 (+69%), and their dip took them to a low of .21 before re-launching as high as 3.00 into the close. That was a mind-boggling 1329% rip.


NuGene International, Inc. NUGN

NUGN has been an ongoing point of interest for us over the past few weeks; we alerted the stock in the third week of June, and at that time, observed a 2.67 swing-low. Since then, the chart has been on a steady incline, surging as much as 47% as it hit a high of 3.88 on both Wednesday and Thursday.

We’ll be looking for the possibility of the stock cracking through that resistance to continue its uptrend into this week.

There’s a fresh PR coming off of the wire this morning as well:

IRVINE, Calif., July 6, 2015 /PRNewswire/ — NuGene International, Inc. (“NuGene”) (NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, conducted one-on-one meetings with top beauty editors in New York City including Allure, Vogue, Glamour, Marie Claire, Self, Shape, More, Town and Country, People, People Style Watch, Cosmopolitan, Better Homes and Gardens and W. >> View PR


Extended Watchlist:
PVSP, WTW, ONCY, JDST, CLSN, ASTI, ENZN